NBIX
USDNeurocrine Biosciences Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$141.970
High
$143.870
Low
$140.820
Volume
0.26M
Company Fundamentals
Market Cap
14.3B
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.86M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Truist Securities Reiterates Buy on Neurocrine Biosciences, Raises Price Target to $172
Truist Securities analyst Danielle Brill reiterates Neurocrine Biosciences with a Buy and raises the price target from $165 to $172.
Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $164
Canaccord Genuity analyst Sumant Kulkarni maintains Neurocrine Biosciences with a Buy and raises the price target from $160 to $164.
Stifel Maintains Buy on Neurocrine Biosciences, Raises Price Target to $183
Stifel analyst Paul Matteis maintains Neurocrine Biosciences with a Buy and raises the price target from $174 to $183.
RBC Capital Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $160
RBC Capital analyst Brian Abrahams maintains Neurocrine Biosciences with a Outperform and raises the price target from $156 to $160.
Piper Sandler Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $179
Piper Sandler analyst David Amsellem maintains Neurocrine Biosciences with a Overweight and raises the price target from $175 to $179.
Needham Maintains Buy on Neurocrine Biosciences, Raises Price Target to $184
Needham analyst Ami Fadia maintains Neurocrine Biosciences with a Buy and raises the price target from $170 to $184.
UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $195
UBS analyst Ashwani Verma maintains Neurocrine Biosciences with a Buy and raises the price target from $188 to $195.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.